Skip to main content
. 2017 Jul 20;36:59. doi: 10.1186/s40880-017-0227-2

Fig. 1.

Fig. 1

Overall survival (OS) curves estimated by the Kaplan–Meier method for patients with intermediate to advanced hepatocellular carcinoma (HCC) who were treated with transarterial chemoembolization (TACE) with or without H101